机构：[1]Department of Hepatology, Beijing You-An Hospital, Capital Medical University, Beijing 100069, China.[2]Department of Interventional Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.[3]Department of Hepatobiliary Surgery, The Fifth Medical Center of PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing 100039, China.[4]Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.[5]Department of Hepatobiliary Surgery, Peking University Cancer Hospital and Institute, Beijing 100142, China.[6]Department of General Surgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.外科系统普通外科首都医科大学宣武医院[7]Department of Hepatobiliary Surgery, Beijing You-An Hospital, Capital Medical University, Beijing 100054, China.[8]Department of General Surgery, Peking University First Hospital, Beijing 100034, China.[9]Department of Hepatobiliary Surgery, Peking Union Medical College Hospital, Beijing 100021, China.[10]Department of Interventional Radiology, Peking University Cancer Hospital and Institute, Beijing 100142, China.[11]Department of Hepatobiliary Surgery, Peking University People's Hospital, Beijing 100044, China.
第一作者机构：[1]Department of Hepatology, Beijing You-An Hospital, Capital Medical University, Beijing 100069, China.
共同第一作者：
通讯作者：
通讯机构：[4]Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.[*1]Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
推荐引用方式(GB/T 7714)：
Meng Qinghua,Yang Zhengqiang,Zhu Zhenyu,et al.Chinese expert consensus on the overall management of liver function in conversion therapy for liver cancer (2022 edition)[J].CHINESE MEDICAL JOURNAL.2023,136(24):2909-2911.doi:10.1097/CM9.0000000000002950.
APA：
Meng Qinghua,Yang Zhengqiang,Zhu Zhenyu,Li Juan,Bi Xinyu...&Cai Jianqiang.(2023).Chinese expert consensus on the overall management of liver function in conversion therapy for liver cancer (2022 edition).CHINESE MEDICAL JOURNAL,136,(24)
MLA：
Meng Qinghua,et al."Chinese expert consensus on the overall management of liver function in conversion therapy for liver cancer (2022 edition)".CHINESE MEDICAL JOURNAL 136..24(2023):2909-2911
